Dendritic Golgi as key cause of degenerative brain disease

August 11, 2017, DGIST (Daegu Gyeongbuk Institute of Science and Technology)
This figure shows degeneration of dendritic-specific Golgi complex in the brain cells by accumulation of polyglutamine toxic protein in the nucleus and its mechanism of early neuropathy. A comparison of brain cell in normal (left) and brain cell (right) in patients with degenerative brain disease. The study has demonstrated for the first time in the world that the polyglutamine toxin protein accumulated in the nucleus of the brain cell inhibits the transcription factors CBP and CrebA. As a result, the dendritic-specific Golgi cannot be properly formed and causes the morphological transformation of the brain cell. Credit: DGIST

A joint research team of DGIST (Daegu Gyeongbuk Institute of Science and Technology) has identified the early neuropathic mechanism of polyglutamine brain disease, one of the representative degenerative brain diseases. They team's findings could accelerate the development of early neuropathy treatment for a variety of degenerative brain diseases, including dementia, Parkinson's disease and Lou Gehrig's disease, which are commonly known to be caused by toxic proteins.

The elderly population has grown with the advancement of medical technology. In Korea, one in 10 elderly people aged 65 or older in recent years suffers from dementia. With the increasing number of patients suffering from intractable degenerative brain , many studies have sought the development of .

Unfortunately, the patients who seek doctors for treatment of degenerative brain diseases are likely already to have significant damage to and it is difficult to expect an effective recovery via commercially available therapeutic agents. Therefore, it is essential to understand how degenerative brain disease progresses in the early stage.

The research teams led by Professor Sung Bae Lee and Professor Daehee Hwang have verified for the first time that dendritic-specific Golgi, a cellular organelle in neurons, plays a key role in the early of degenerative brain disease.

In a model of degenerative brain diseases caused by polyglutamine toxic protein such as Huntington's chorea and spinal cord cerebellar degeneration, the research teams found that the deformation or abnormality of dendritic-specific Golgi, which play a key role in the cell membrane of brain , is the major cause of degenerative brain disease leading to morphological transformation of neuronal cells.

The study has demonstrated that the early neuropathy of diseased brain cells can be restored by inducing overexpression of the CrebA gene, a newly discovered key factor in pathology. In addition, by identifying the transcription factors involved in the early neuropathy caused by toxic proteins such as CrebA and high-level factor CBP, the researchers have suggested that they could be new subjects to develop therapeutic agents for degenerative brain diseases.

DGIST Professor Sung Bae Lee said, "We have verified that the dendrite-specific Golgi of brain cells play a core role in the early neuropathy of . By restoring the early stages of the disease, we expect to accelerate the development of therapeutic drugs that can effectively treat degenerative diseases."

This study has been published in the online edition of Cell Reports, an international journal of life science and the sister journal of Cell, on July 11.

Explore further: Discovery may offer hope to Parkinson's disease patients

More information: Chang Geon Chung et al, Golgi Outpost Synthesis Impaired by Toxic Polyglutamine Proteins Contributes to Dendritic Pathology in Neurons, Cell Reports (2017). DOI: 10.1016/j.celrep.2017.06.059

Related Stories

Discovery may offer hope to Parkinson's disease patients

May 22, 2017
The finding of a common protein abnormality in these degenerative diseases supports a hypothesis among experts that abnormal deposition of proteins in many neurodegenerative disorders reflects an early change in these proteins.

Connection between brain inflammation and CTE identified

November 2, 2016
For the first time, researchers have shown that inflammation in the brain may have direct involvement in the development of chronic traumatic encephalopathy (CTE). In addition, they found that the number of years one plays ...

Team identifies mechanism of dopaminergic neuronal death inhibition using stress hormone cortisol

April 26, 2017
DGIST's research team has found a candidate substance that can prevent and cure Parkinson's disease. By using this substance, the team also has identified the mechanism of dopaminergic neuronal death inhibition.

Researchers identify potential treatment for type of muscle and brain degenerative disease

March 21, 2017
UCLA researchers have discovered the molecular basis of, and identified potential treatment for, an incurable disease known as inclusion body myopathy, Paget disease with frontotemporal dementia, or IBMPFD. Using both genetically ...

Researchers reveal how neurodegenerative diseases spread through the brain

November 9, 2016
Synapses, the place where brain cells contact one another, play a pivotal role in the transmission of toxic proteins. This allows neurodegenerative diseases such as Alzheimer's to spread through the brain. This the main conclusion ...

New hope for early diagnosis and treatment of Parkinson's

February 15, 2013
Flinders University researchers have discovered that a protein in the brain may play a role in the development of Parkinson's disease – a common degenerative neurological disorder which affects the control of body movements.

Recommended for you

Convergence of synaptic signals is mediated by a protein critical for learning and memory

July 16, 2018
Inside the brain, is a complex symphony of perfectly coordinated signaling. Hundreds of different molecules amplify, modify and carry information from tiny synaptic compartments all the way through the entire length of a ...

Synapse-specific plasticity governs the identity of overlapping memory traces

July 16, 2018
Memories are formed through long-term changes in synaptic efficacy, a process known as synaptic plasticity, and are stored in the brain in specific neuronal ensembles called engram cells, which are activated during corresponding ...

'Concussion pill' shows promise in pre-clinical pilot study

July 16, 2018
In 2016, funded by a $16 million grant from Scythian, the multidisciplinary Miller School team embarked on a five-year study to examine the effects of combining CBD (a cannabinoid derivative of hemp) with an NMDA antagonist ...

Fetal gene therapy prevents fatal neurodegenerative disease

July 16, 2018
A fatal neurodegenerative condition known as Gaucher disease can be prevented in mice following fetal gene therapy, finds a new study led by UCL, the KK Women's and Children's Hospital and National University Health System ...

Rehabilitating the mind could improve outcomes after spinal cord injury

July 16, 2018
A study led by Heriot-Watt University has explored how individuals with spinal cord injuries perceive the space around them. The findings suggest additions are needed to the rehabilitation programmes adopted post-injury to ...

Study suggests mice and rats, like humans, make poor choices based on 'sunk costs'

July 13, 2018
A team of researchers at the University of Minnesota has found that mice and rats, like humans, tend to make poor decisions based on "sunk costs." In their paper published in the journal Science, the group describes their ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.